Population pharmacokinetics and site of action exposures of veliparib with topotecan plus carboplatin in patients with haematological malignancies
暂无分享,去创建一个
J. Gobburu | J. Karp | M. Rudek | J. Greer | K. Pratz | Shailly Mehrotra | R. Piekarz | M. Gopalakrishnan